Singh Sandeep Kumar, Banala Venkatesh Teja, Gupta Girish K, Verma Ashwni, Shukla Rahul, Pawar Vivek K, Tripathi Priyanka, Mishra Prabhat Ranjan
a Pharmaceutics Division , CSIR-Central Drug Research Institute , Lucknow , Uttar Pradesh , India .
Drug Dev Ind Pharm. 2015;41(11):1759-68. doi: 10.3109/03639045.2014.1003220. Epub 2015 Sep 10.
The aim of this study was to fabricate docetaxel loaded nanocapsules (DTX-NCs) with a high payload using Layer-by-Layer (LbL) technique by successive coating with alternate layers of oppositely charged polyelectrolytes. Developed nanocapsules (NCs) were characterized in terms of morphology, particle size distribution, zeta potential (ζ-potential), entrapment efficiency and in vitro release. The morphological characteristics of the NCs were assessed using transmission electron microscopy (TEM) that revealed coating of polyelectrolytes around the surface of particles. The developed NCs successfully attained a submicron particle size while the ζ-potential of optimized NCs alternated between (+) 34.64 ± 1.5 mV to (-) 33.25 ± 2.1 mV with each coating step. The non-hemolytic potential of the NCs indicated the suitability of the developed formulation for intravenous administration. A comparative study indicated that the cytotoxicity of positively charged NCs (F4) was significant higher (p < 0.05) rather than negative charged NCs (F3), plain drug (DTX) and marketed preparation (Taxotere®) when evaluated in vitro on MCF-7 cells. Furthermore, cell uptake studies evidenced a higher uptake of positive NCs (≥1.2 fold) in comparison to negative NCs. In conclusion, formulated NCs are an ideal vehicle for passive targeting of drugs to tumor cells that may result in improved efficacy and reduced toxicity of encapsulated drug moiety.
本研究的目的是采用层层(LbL)技术,通过交替涂覆带相反电荷的聚电解质层,制备具有高载药量的多西他赛负载纳米胶囊(DTX-NCs)。对所制备的纳米胶囊(NCs)进行了形态、粒径分布、zeta电位(ζ-电位)、包封率和体外释放等方面的表征。使用透射电子显微镜(TEM)评估了NCs的形态特征,结果显示颗粒表面有聚电解质涂层。所制备的NCs成功获得了亚微米级粒径,优化后的NCs的ζ-电位在每次涂覆步骤中在(+)34.64±1.5 mV至(-)33.25±2.1 mV之间交替变化。NCs的非溶血潜力表明所开发的制剂适用于静脉给药。一项比较研究表明,在体外对MCF-7细胞进行评估时,带正电荷的NCs(F4)的细胞毒性显著高于(p<0.05)带负电荷的NCs(F3)、普通药物(DTX)和市售制剂(泰索帝®)。此外,细胞摄取研究证明,与带负电荷的NCs相比,带正电荷的NCs的摄取量更高(≥1.2倍)。总之,所制备的NCs是将药物被动靶向肿瘤细胞的理想载体,这可能会提高包封药物部分的疗效并降低其毒性。